Table 3

Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus

William B. Messer*, Duane J. Gubler†, Eva Harris‡, Kamalanayani Sivananthan§, and Aravinda M. de Silva*

Author affiliations: *University of North Carolina, Chapel Hill, North Carolina, USA; †Centers for Disease Control and Prevention, Fort Collins, Colorado, USA; ‡University of California, Berkeley, California, USA; §Medical Research Institute, Colombo, Sri Lanka.

Main Article

Nucleotide substitutions conserved within dengue virus 3, subtype III groups^a

338	429	503	566	653	686	695	707	728	734	749	791	821	866	896	902	978	1010	1019	1056

Reference	H87	A	A	C	G	G	T	T	G	C	C	C	A	T	C	T	T	C	C	T	C
Group A	83SriLan1	-	G	T	A	-	-	C	-	-	T	T	-	-	T	C	C	T	T	-	-
Group A	83SriLan2	-	G	T	A	-	-	C	-	-	T	T	-	-	T	C	C	T	T	-	-
Group A	83SriLan3	-	G	T	A	-	-	C	-	-	-	T	-	-	T	-	C	-	T	-	-
Group A	83SriLan4	-	G	T	A	-	-	C	-	-	T	T	-	-	T	C	C	T	T	-	-
Group A	84SriLan1	-	G	-	-	-	-	-	-	-	-	T	-	-	-	C	-	-	-	-	-
Group A	85SriLan1	-	G	T	A	-	-	C	-	-	T	T	-	-	T	C	C	T	T	-	-
Group A	89SriLan2	-	G	T	A	-	-	C	-	-	T	T	-	-	T	C	C	T	T	-	-
unclassified	84India	G	G	-	-	A	-	-	-	-	-	T	-	-	-	-	-	-	-	G	-
unclassified	93SriLan1	G	G	-	-	A	-	-	-	-	-	-	-	-	-	-	-	-	-	G	-
East Africa	85Mozamb1	G	-	-	-	A	-	-	-	-	-	-	-	-	-	-	-	-	-	G	-
East Africa	85Mozamb2	G	-	-	-	A	-	-	-	-	-	-	-	-	-	-	-	-	-	G	-
East Africa	85Mozamb3	G	-	-	-	A	-	-	-	-	-	-	-	-	-	-	-	-	-	G	-
East Africa	91Kenya	G	-	-	-	A	-	-	-	-	-	-	-	-	-	-	-	-	-	G	-
East Africa	93Somalia	G	-	-	-	A	-	-	-	-	-	-	-	-	-	-	-	-	-	G
Group B	89SriLan1	G	G	-	-	A	-	-	A	T	-	-	-	C	-	-	-	-	-	G	-
Group B	89SriLan3	-	G	-	-	A	-	-	A	T	-	-	-	C	-	-	-	-	-	G	-
Group B	90SriLan1	G	G	-	-	A	-	-	A	T	-	-	-	C	-	-	C	-	-	G	-
Group B	94SriLan1	-	G	-	-	A	-	-	A	T	-	-	-	C	-	-	-	-	-	G	-
Group B	97SriLan1	G	G	-	-	A	-	-	A	T	T	-	-	C	-	C	-	-	-	G	-
Group B	98SriLan1	G	G	-	-	A	-	-	A	T	-	-	-	C	-	C	-	-	-	G	-
L. America	94Nicara1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	94Panama1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	94Panama2	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	94Panama3	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	CostaRica1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	CostaRica2	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	CostaRica3	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	CostaRica4	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	96Mexico1	G	G	-	-	A	C	C	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	96Mexico2	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	96Mexico3	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	96Mexico4	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	97Guatem1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	98Nicara1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	98Nicara2	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	98Nicara3	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	98ElSalv1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	01Venezue1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	01VEN03	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	98PuertoR1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T
L. America	00PuertoR1	G	G	-	-	A	C	-	-	-	-	-	G	C	-	-	-	-	-	G	T

^aReference strain is the highly passaged laboratory strain H87. Positions are numbered sequentially from the first nucleotide position at the 5¢ end of the genome.

Main Article

Page created: December 22, 2010

Page updated: December 22, 2010

Page reviewed: December 22, 2010

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.